ArticleInternational cancer conference journal2022

Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma.

Jun Nukui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.